ZOM stock could provide some good gains in the long term if its veterinary diagnostic and therapeutic technologies can gain sufficient market traction. However, the stock remains a speculative investment that owed its previous tops to the Reddit meme that lifted other stocks like GameStop and AMC.
Similarly Why is ZOM dropping? CEO Robert Cohen said the move was precipitated by « changes at our current distributor that we believe have impacted its ability to market our products effectively. » Those words likely startled investors, many of whom decided to sell their shares. Zomedica’s stock price dropped sharply on Thursday.
Will ZOM recover? ZOM stock will likely struggle to recover in price over the next few months. It’s going to be awhile before this early stage company will again have the chance to prove itself to investors. Having said that, investors with a high appetite for risk, and a willingness to go against the grain, may want to buy today.
Additionally, What is Zomedica stock forecast?
Stock Price Forecast
The 1 analysts offering 12-month price forecasts for Zomedica Corp have a median target of 1.20, with a high estimate of 1.20 and a low estimate of 1.20. The median estimate represents a +292.16% increase from the last price of 0.31.
Will ZOM be delisted?
(NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”) a veterinary diagnostic and pharmaceutical company, today announced that it has received approval of its application to delist its common shares from the TSX Venture Exchange (“TSXV”) effective at the close of business on February 10, 2020.
Is ZOM undervalued? InvestorPlace’s Mark Hake estimates Zomedica (NYSEAMERICAN:ZOM) is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy at current prices.
Is ZOM stock overvalued? The Zomedica Pharmaceuticals Corp stock price gained 1.96% on the last trading day (Thursday, 14th Apr 2022), rising from $0.30 to $0.31.
…
Predicted Opening Price for Zomedica Pharmaceuticals Corp of Monday, April 18, 2022.
| Fair opening price April 18, 2022 | Current price |
|---|---|
| $0.30 | $0.31 (Overvalued) |
Is ZOM overvalued? Zomedica Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology.
Is ZOM a meme stock?
A couple of meme stocks that stand out as incredibly risky today are Zomedica ( ZOM 1.80% ) and Digital World Acquisition Corp ( DWAC 0.73% ).
How many shares of ZOM are there? Share Statistics
| Avg Vol (3 month) 3 | 17.3M |
|---|---|
| Shares Outstanding 5 | 979.9M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 965.89M |
| % Held by Insiders 1 | 2.63% |
When did ZOM go public?
On April 18, 2019, the company became a public company via an initial public offering. After pricing at US$36 per share, the share price increased over 72% on the first day of trading. Prior to the IPO, Dropbox invested $5 million in Zoom.
Will NAKD stock recover? NAKD stock became a hit with the Reddit trading crowd and has done well to fortify its balance sheet. It’s now debt-free and has evolved into a pure-play e-commerce business. Unfortunately, there are several loopholes in its turnaround strategy, so it is unlikely things will change significantly for the company.
Is ZOM a buy Zacks?
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months .
…
(Delayed Data from AMEX)
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
Who owns the most ZOM stock?
Top 10 Owners of Zomedica Corp
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 4.14% | 40,612,378 |
| SSgA Funds Management, Inc. | 2.93% | 28,730,202 |
| BlackRock Fund Advisors | 1.19% | 11,691,103 |
| Cambridge Investment Research Adv… | 1.14% | 11,142,660 |
What is Truforma? Truforma is a blood testing kit for veterinarians. It’s based on bulk acoustic wave (BAW) sensors from Qorvo (NASDAQ:QRVO). The waves are run through pet blood samples to test for adrenal and thyroid diseases.
Who bought Zom stock? Top 10 Owners of Zomedica Corp
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| The Vanguard Group, Inc. | 4.14% | +181,358 |
| SSgA Funds Management, Inc. | 2.93% | +5,932,371 |
| BlackRock Fund Advisors | 1.19% | -5,530,082 |
| Cambridge Investment Research Adv… | 1.14% | +845 |
Who bought Zom?
Pinnacle Wealth Management Group, Inc.
Did BlackRock buy Zom stock? – 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. reports 29.83% decrease in ownership of ZOM / Zomedica Pharmaceuticals Corp.
| Security | ZOM / Zomedica Pharmaceuticals Corp. |
|---|---|
| Latest Disclosed Value | $ 3,896,000 |
Is Zoom Chinese owned?
Zoom is a U.S.-founded company and its founder Eric Yuan is a Chinese immigrant who is now an American citizen. However, the company’s development team is “largely” based in China, according to Zoom’s regulatory filing from earlier this year.
Is Zoom owned by China? Zoom or Zoom Communications, Inc. is not a Chinese company at all but in fact, an American company founded by Chinese-American billionaire Eric Yuan. It is headquartered in San Jose, California and Yuan, who is also the CEO of Zoom, holds American citizenship.
What company owns Zoom stock?
Top 10 Owners of Zoom Video Communications Inc
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| The Vanguard Group, Inc. | 5.11% | +68,950 |
| Morgan Stanley Investment Managem… | 3.95% | +293,076 |
| Baillie Gifford & Co. | 3.17% | -128,943 |
| BlackRock Fund Advisors | 3.00% | +191,170 |
Is Naked stock a buy? It has been an extraordinary year, and to be fair, still a profitable one: NAKD stock has still gained 74% so far in 2021. 2022 should be quieter, at least on a relative basis, as Naked becomes Cenntro Automotive.
What will happen to NAKD stock after merger? Per the terms of the merger, existing NAKD shareholders will own 30% of the combined company. Cenntro’s existing investors will hold the other 70%.
Is XOM a buy or sell?
Exxon Mobil currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
